.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,828,299

« Back to Dashboard

Details for Patent: 6,828,299

Title: Polyhydroxy glycopeptide derivatives
Abstract:Disclosed are polyhydroxy derivatives of glycopeptides and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.
Inventor(s): Yang; Guang (San Mateo, CA), Schmidt, Jr.; Donald E. (Brisbane, CA), Judice; J. Kevin (El Granada, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Filing Date:May 01, 2001
Application Number:09/847,061
Claims:1. A modified glycopeptide of formula II: ##STR18##

wherein: R.sup.3 is --OH; R.sup.5 is hydrogen; R.sup.19 is hydrogen; R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b (Z).sub.x or --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --R.sup.17 ; within R.sup.20 moiety R.sup.17 is hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl or heterocyclic; within moiety R.sup.20 Y is selected from the group consisting of oxygen, sulfur, --S--S--, NR.sup.c --, --S(O)--, --SO.sub.2 --, --NR.sup.c C(O)--, --OSO.sub.2 --, --OC(O)--, --NR.sup.c SO.sub.2 --, --C(O)NR.sup.c --, --C(O)O--, --SO.sub.2 NR.sup.c --, --SO.sub.2 O--, --P(O)(OR.sup.c)O--, --P(O)(OR.sup.c)NR.sup.c --, --OP(O)(OR.sup.c)O--, --OP(O)(OR.sup.c)NR.sup.c --, --OC(O)O--, --NR.sup.c C(O)O--,--NR.sup.c C(O)NR.sup.c --, --OC(O)NR.sup.c --, --C(.dbd.O)--and --NR.sup.c SO.sub.2 NR.sup.c --; within R.sup.20 moiety each Z is independently selected from the group consisting of hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic and x is 1 or 2; within Y moiety R.sup.b is selected from the group consisting of a covalent bond, alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene and substituted alkynylene, provided R.sup.b is not a covalent bond when Z is hydrogen; each R.sup.c is independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl, heterocyclic and --C(O)R.sup.d ; within R.sup.c moiety each R.sup.d is independently selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl and heterocyclic; and or a pharmaceutically acceptable salt or a stereoisomer thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of claim 1.

3. The pharmaceutical composition of claim 2, wherein the composition further comprises a cyclodextrin.

4. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --R.sup.17 and R.sup.17 is alkyl.

5. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --R.sup.17 and R.sup.17 is aryl.

6. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b --(Z).sub.x and Y is an --NH--group Z is independently selected from the group consisting of hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic; and x is 1 or 2.

7. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b --(Z).sub.x and Y is oxygen Z is independently selected from the group consisting of hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic; and x is 1 or 2.

8. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b --(Z).sub.x and Y is sulfur Z is independently selected from the group consisting of hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic; and x is 1 or 2.

9. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b --(Z).sub.x and R.sup.b is alkylene Z is independently selected from the group consisting of hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic; and x is 1 or 2.

10. The glycopeptide of claim 1, wherein R.sup.20 is --CH.sub.2 --CH(OH)CH(OH)CH.sub.2 --Y--R.sup.b --(Z).sub.x and Z is hydrogen and x is 1 or 2.

11. The glycopeptide of claim 1, wherein R.sup.20 has the structure: ##STR19##

12. The glycopeptide of claim 1, wherein R.sup.20 has the structure: ##STR20##

13. The glycopeptide of claim 1, wherein R.sup.20 has the structure: ##STR21##

14. The glycopeptide of claim 1, wherein R.sup.20 has the structure: ##STR22##

15. A method of treating a bacterial disease in a mammal comprising administering to the mammal a therapeutically effective amount of a glycopeptide of claim 1.

16. A method of treating a bacterial disease in a mammal comprising administering to the mammal a therapeutically effective amount of a pharmaceutical composition of claim 2.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc